The IGF-1 is involved in androgen-independent progression of prostate cancer and leptin induces migration in prostate cancer cells, thus obesity-induced hormonal changes may promote tumour progression (Amling et al, 2004; Freedland et al, 2004). Here, LEP is linked to prostate carcinoma.